课题基金 / 基金详情

Interaction of the Microbiome and Genetic Architecture in Chronic Immune Mediated Hepatobiliary Diseases

Interaction of the Microbiome and Genetic Architecture in Chronic Immune Mediated Hepatobiliary Diseases
慢性免疫介导的肝胆疾病中微生物组和遗传结构的相互作用
批准号:
276974
负责人:
Mason Andrew L
金额:
$0.87万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-11-01 至 2013-11-01

项目摘要

项目成果

Mason Andrew L的其他基金

相似基金

相关文献

中文摘要
翻译
几种导致肝脏衰竭的知之甚少的疾病被称为自身免疫性肝胆疾病。这些疾病包括胆管疾病、胆道闭锁、原发性硬化性胆管炎和原发性胆汁性肝硬化,
英文摘要
Several poorly understood diseases that result in failure of the liver are referred to as autoimmune hepatobiliary diseases. These include the bile duct diseases, biliary atresia, primary sclerosing cholangitis and primary biliary cirrhosis as well as aut
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Does Human Betaretrovirus (HBRV) infection predate the development of Breast Cancer?
  • 批准号:
    436860
  • 项目类别:
    Operating Grants
  • 资助金额:
    $10.93万
  • 财政年份:
    2020
  • 负责人:
    Mason Andrew L
  • 依托单位:
Translational studies to test potential therapies for patients with primary biliary cirrhosis
  • 批准号:
    304870
  • 项目类别:
    Operating Grants
  • 资助金额:
    $55.95万
  • 财政年份:
    2014
  • 负责人:
    Mason Andrew L
  • 依托单位:
Isolation of a novel human retrovirus associated with primary biliary cirrhosis and fulfillment of koch's postulates in vitro
  • 批准号:
    223288
  • 项目类别:
    Operating Grants
  • 资助金额:
    $31.05万
  • 财政年份:
    2011
  • 负责人:
    Mason Andrew L
  • 依托单位:
Pilot study of highly active anti-retroviral therapy for patients with primary biliary cirrhosis
  • 批准号:
    223750
  • 项目类别:
    Operating Grants
  • 资助金额:
    $36.88万
  • 财政年份:
    2011
  • 负责人:
    Mason Andrew L
  • 依托单位:
海外基金